Omron Corp. (OTCMKTS:OMRNY) Short Interest Update

Omron Corp. (OTCMKTS:OMRNYGet Free Report) saw a significant decrease in short interest in the month of March. As of March 13th, there was short interest totaling 19,212 shares, a decrease of 30.5% from the February 26th total of 27,640 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 87,248 shares, the short-interest ratio is presently 0.2 days.

Omron Stock Down 3.0%

Shares of OTCMKTS OMRNY opened at $26.95 on Friday. The firm has a market cap of $5.56 billion, a price-to-earnings ratio of 34.11, a PEG ratio of 0.42 and a beta of 0.92. The company has a quick ratio of 1.37, a current ratio of 2.11 and a debt-to-equity ratio of 0.13. Omron has a 52-week low of $23.23 and a 52-week high of $35.90. The business’s 50 day moving average is $29.30 and its two-hundred day moving average is $27.53.

Omron (OTCMKTS:OMRNYGet Free Report) last released its quarterly earnings results on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.19). The firm had revenue of $1.41 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Research analysts predict that Omron will post 0.42 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC lifted its holdings in Omron Corp. (OTCMKTS:OMRNYFree Report) by 50.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. Institutional investors own 1.09% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

Read Our Latest Report on Omron

Omron Company Profile

(Get Free Report)

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Featured Articles

Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.